A company still losing money with steady sales. Insiders and institutions are both adding.
Facts from SEC filings, not a recommendation.
Last 12 months: $62.8M, up 16% from the 12 months before.
Price chart by TradingView.
From annual reports filed with the SEC. Not in this company's SEC data, so not scored: profitable every year, share count not growing, gross margin 40%+. A checklist is a starting point for research, not a verdict.
50 is neutral. Buying by more insiders, top executives and bigger stakes raises it. Selling lowers it; pre-planned sales count less.
SEC filings of any kind. 50 means a normal week.
Institutions added 47.4% to their holdings. 19 bought, 10 sold. 3 quarters of net buying in a row.
| Insider | Trade | Shares | Avg price | Value | Owns after | Date |
|---|---|---|---|---|---|---|
D Jonathan MerrimanDirector | Buy | 5K | $2.08 | $10K | 391K | Oct 8Filing ↗ |
| ||||||
D Jonathan MerrimanDirector | Buy | 7K | $2.21 | $15K | 386K | Sep 30Filing ↗ |
| ||||||
D Jonathan MerrimanDirector | Buy | 11K | $2.21 | $24K | 379K | Sep 24Filing ↗ |
| ||||||
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
4,700 shares at $2.08 · $10K
7,000 shares at $2.21 · $15K
11,000 shares at $2.21 · $24K
6,700 shares at $2.36 · $16K
374,109 shares
7,700 shares at $2.30 · $18K
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page